MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

about

Exploring ribosome composition and newly synthesized proteins through proteomics and potential biomedical applications.Release of MicroRNAs into Body Fluids from Ten Organs of Mice Exposed to Cigarette Smoke.

P2860

Q39322729-1911918B-1EE4-4088-8B8C-F54A5F0A1D54 Q52714388-47107B9E-BA17-40C8-B640-85C6DC63CF7B

P2860

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

Item

http://www.wikidata.org/entity/Q39002848

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

@en

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated.

@nl

type

Item

label

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

@en

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated.

@nl

prefLabel

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

@en

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated.

@nl

P1476

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

@en

P2093

Eunhyun Choi

http://www.w3.org/2001/XMLSchema#string

Ki-Chul Hwang

http://www.w3.org/2001/XMLSchema#string

Seahyoung Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Man Kim

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

Long non-coding RNAs: insights into functions

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation

Treatment of HCV infection by targeting microRNA

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?

Towards the discovery of drug-like RNA ligands?

MicroRNAs add a new dimension to cardiovascular disease

MicroRNAs: novel players in cancer diagnosis and therapies.

Targeting RNA by small molecules: comparative structural and thermodynamic aspects of aristololactam-β-D-glucoside and daunomycin binding to tRNA(phe)

P304

34-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4331/WJBC.V6.I2.34

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276441330

http://www.w3.org/2001/XMLSchema#string

P698

26009702

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

cardiovascular disease

P932

4436904

http://www.w3.org/2001/XMLSchema#string

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

about

P2860

P2860

MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932